Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12409195 | Bacteria engineered to reduce hyperphenylalaninemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Yves Millet, Sarah Rowe | 2025-09-09 |
| 11896627 | Bacteria engineered to treat metabolic diseases | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Sarah Rowe, Yves Millet +1 more | 2024-02-13 |
| 11883439 | Bacteria engineered to treat a disease or disorder | Dean Falb, Paul F. Miller, Jonathan W. Kotula, Suman Machinani, Adam B. Fisher +1 more | 2024-01-30 |
| 11879123 | Bacteria for the treatment of disorders | Dean Falb, Adam B. Fisher, Jonathan W. Kotula, David Lubkowicz, Paul F. Miller +2 more | 2024-01-23 |
| 11859189 | Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof | Dylan Alexander Carlin, Jonathan McMurry, Theodore Carlton Moore, III, Mylene Perreault, Nathan W. Schmidt +1 more | 2024-01-02 |
| 11845964 | Bacteria engineered to treat diseases associated with hyperammonemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Suman Machinani | 2023-12-19 |
| 11723932 | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Suman Machinani, Saurabh Saha +3 more | 2023-08-15 |
| 11685925 | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Yves Millet, Adam B. Fisher | 2023-06-27 |
| 11618894 | Bacteria engineered to reduce hyperphenylalaninemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Sarah Rowe, Yves Millet | 2023-04-04 |
| 11471494 | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Suman Machinani, Saurabh Saha +4 more | 2022-10-18 |
| 11439673 | Bacteria engineered to treat liver disease | Paul F. Miller, Dean Falb, Jonathan W. Kotula, Yossi Dagon | 2022-09-13 |
| 11384359 | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Yves Millet, Adam B. Fisher | 2022-07-12 |
| 11291693 | Bacteria engineered to treat metabolic diseases | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Sarah Rowe, Yves Millet +1 more | 2022-04-05 |
| 11273184 | Bacteria engineered to treat disorders in which oxalate is detrimental | Dean Falb, Cami Leigh Anderson, Paul F. Miller, Yves Millet, Jonathan W. Kotula | 2022-03-15 |
| 11060073 | Bacteria engineered to treat diseases associated with hyperammonemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Suman Machinani | 2021-07-13 |
| 10933102 | Bacteria engineered to treat a disease or disorder | Dean Falb, Paul F. Miller, Jonathan W. Kotula, Suman Machinani, Adam B. Fisher +1 more | 2021-03-02 |
| 10610546 | Bacteria engineered to reduce hyperphenylalaninemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Yves Millet, Sarah Rowe | 2020-04-07 |
| 10273489 | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier | Dean Falb, Jonathan W. Kotula, Paul F. Miller | 2019-04-30 |
| 10195234 | Bacteria engineered to reduce hyperphenylalaninemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Sarah Rowe, Yves Millet | 2019-02-05 |
| 9943555 | Bacteria engineered to reduce hyperphenylalaninemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Yves Millet, Sarah Rowe | 2018-04-17 |
| 9889164 | Bacteria engineered to treat a disease or disorder | Dean Falb, Paul F. Miller, Jonathan W. Kotula, Suman Machinani, Adam B. Fisher +1 more | 2018-02-13 |
| 9688967 | Bacteria engineered to treat diseases associated with hyperammonemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller, Suman Machinani | 2017-06-27 |
| 9487764 | Bacteria engineered to treat diseases associated with hyperammonemia | Dean Falb, Jonathan W. Kotula, Paul F. Miller | 2016-11-08 |